Unknown

Dataset Information

0

Effect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery.


ABSTRACT: Antibodies to complexes of heparin and platelet factor 4 (PF4) are capable of causing heparin-induced thrombocytopenia (HIT). Recent evidence suggests that anti-PF4/heparin antibodies may be prothrombogenic even in the absence of thrombocytopenia and clinically-recognized HIT.To determine if induction of anti-PF4/heparin antibodies is an independent risk factor for early saphenous vein graft (SVG) occlusion or adverse clinical outcome after coronary artery bypass graft (CABG) surgery.Anti-PF4/heparin antibody titers were measured in 368 patients prior to and then 4 days, 6 weeks and 6 months after CABG surgery. Serotonin release assay (SRA) and antibody isotype analysis were also performed on 6-week samples. SVG patency was determined in 297 patients 6 months after surgery by multidetector computed tomography coronary angiography.Six weeks after surgery, 52% of patients were anti-PF4/heparin seropositive and 9% were SRA positive. Six months after surgery, neither the percentage of occluded SVG (19% vs. 20%, P = NS), the percentage of patients with an occluded SVG (33% vs. 33%, P = NS) nor the incidence of adverse clinical events (21% vs. 24%, P = NS) differed between seropositive and seronegative groups. Neither IgG isotype nor SRA positivity was additionally predictive of SVG occlusion or adverse clinical outcome.Induction of anti-PF4/heparin antibodies, even those capable of heparin-dependent platelet activation, is not independently associated with early SVG occlusion or adverse clinical outcomes after CABG surgery.

SUBMITTER: Gluckman TJ 

PROVIDER: S-EPMC3004149 | biostudies-literature | 2009 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery.

Gluckman T J TJ   Segal J B JB   Schulman S P SP   Shapiro E P EP   Kickler T S TS   Prechel M M MM   Conte J V JV   Walenga J M JM   Shafique I I   Rade J J JJ  

Journal of thrombosis and haemostasis : JTH 20090623 9


<h4>Background</h4>Antibodies to complexes of heparin and platelet factor 4 (PF4) are capable of causing heparin-induced thrombocytopenia (HIT). Recent evidence suggests that anti-PF4/heparin antibodies may be prothrombogenic even in the absence of thrombocytopenia and clinically-recognized HIT.<h4>Objectives</h4>To determine if induction of anti-PF4/heparin antibodies is an independent risk factor for early saphenous vein graft (SVG) occlusion or adverse clinical outcome after coronary artery b  ...[more]

Similar Datasets

| S-EPMC10081881 | biostudies-literature
| S-EPMC10902658 | biostudies-literature
| S-EPMC3653490 | biostudies-literature
| S-EPMC4206593 | biostudies-literature
| S-EPMC8387700 | biostudies-literature
| S-EPMC3560373 | biostudies-literature
| S-EPMC3089948 | biostudies-literature
| S-EPMC5660200 | biostudies-literature
| S-EPMC7361649 | biostudies-literature
| S-EPMC6258143 | biostudies-literature